The patients must be encouraged to follow the specific recommendations to avoid/mitigate diarrhoea (Table 2, Figure 1, Figure 2 and Figure 3), which should already have been taught to them as part of their education prior to GLP-1 RA initiation
In the UK, the regulatory pathway for new medicines requires the MHRA to assess comprehensive evidence of safety, efficacy, and quality before granting a marketing authorisation
102 The FDA set several usage restrictions upon the initial approval of Tanzeum (albiglutide), reflecting considerations of suitability and safety for specific patient groups
results varied across dose groups and this context is important when interpreting the data GI side effects were the most common adverse events, consistent with the GLP-1 class, and were predominantly mild to moderate in severity, declining over time Small increases in heart rate and gallbladder-related events were also observed, consistent with class effects The trial was of limited duration